SCHEMBL10840624

SCHEMBL10840624

Nc1ccccc1Cc1nc[nH]n1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.44
ALDH1A1 P00352 1/20 0.33
EGFR P00533 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.32
CYP3A4 P08684 1/20 0.32
ALOX15 P16050 1/20 0.32
CASP1 P29466 1/20 0.32
CASP7 P55210 1/20 0.32
ATP4A P20648 2/20 0.32
ATP4B P51164 2/20 0.32
FDPS P14324 1/20 0.32
CYP1A2 P05177 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
YTHDC1 Q96MU7 1/20 0.30
IDO1 P14902 4/20 0.30
NPC1 O15118 1/20 0.30
RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10504825 0.76 SMN1; SMN2 (0.38) ALDH1A1SMN1; SMN2CYP3A4ALOX15ATP4A
SCHEMBL36019 0.72 CYP3A4 (0.53) ARALDH1A1SMN1; SMN2CYP3A4ALOX15
SCHEMBL29373097 0.72 CYP3A4 (0.53) ARALDH1A1SMN1; SMN2CYP3A4ALOX15
Hydrochloric Acid SCHEMBL9382673 0.71 TAAR1 (0.46) ARSMN1; SMN2CYP1A2
SCHEMBL10505088 0.70 AR (0.44) ARALDH1A1SMN1; SMN2ATP4AATP4B
SCHEMBL10505415 0.70 AR (0.44) ARATP4AATP4BYTHDC1
SCHEMBL9719138 0.70 CYP3A4 (0.50) ARALDH1A1SMN1; SMN2CYP3A4ALOX15
Hydrochloric Acid SCHEMBL11743462 0.70 CYP3A4 (0.50) ARALDH1A1SMN1; SMN2CYP3A4ALOX15
Ammonia Solution, Strong SCHEMBL9517239 0.70 CYP3A4 (0.50) ARALDH1A1SMN1; SMN2CYP3A4ALOX15
SCHEMBL1759362 0.70 CYP3A4 (0.50) ARALDH1A1SMN1; SMN2CYP3A4ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4595535-A Schizophrenia CIBA-GEIGY CORPORATION (US) 1986-06-17 US disclosed
EP-0129509-A2 Triazolo (2,3-c)(1,3)benzodiazepines, process for their preparation, pharmaceutical compositions containing them and their therapeutical use CIBA-GEIGY AG (CH) 1984-12-27 EP disclosed